Publications
Review Article
Immunotherapy for breast cancer
2002
Authors:
Knutson KL, Bishop MR, Schiffman K, and Disis ML
Journal:
Cancer Chemotherapy and Biological Response Modifiers Annual
Volume:
20
Page:
351-69
Review Article
Immunologic targets for breast cancer
Cancer Vaccines
2002
Authors:
Disis ML
Journal:
Breast Disease
Volume:
15
Page:
83-90
Review Article
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy
Measuring Human Immunity
2002
Authors:
Kielholz U, Weber J, Finke J, Gabrilovich D, Kast M, Disis ML, Kirkwood J, Scheibenbogen C, Scholm J, Maino V, Lyerly HK, See P, Storkus W, Marincola F, Worobec A, Atkins MB
Journal:
Journal of Immunotherapy
Volume:
25(2)
Page:
97-138
Review Article
Cancer vaccines targeting the HER2/neu oncogenic protein
Cancer Vaccines
2002
Authors:
Disis ML
Journal:
Biological Therapy of Breast Cancer
Volume:
4(3)
Page:
11-4
Original Article
Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients
General Immune Research
2002
Authors:
Schiffman K, Rinn K, Disis ML
Journal:
Breast Cancer Research and Treatment
Volume:
74(1)
Page:
17-23
Original Article
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers
Cancer Vaccines
2002
Authors:
Disis ML, Rinn K, Knutson KL, Davis D, Caron D, dela Rosa C, Schiffman K
Journal:
Blood
Volume:
99(8)
Page:
2845-50
Review Article
Update on Breast Cancer Vaccines
2002
Authors:
Schiffman K and Disis ML
Journal:
Diseases of the Breast
Volume:
5(2)
Page:
1-14
Pubmed:
Original Article
Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient
Cancer Vaccines
2002
Authors:
Knutson KL and Disis ML
Journal:
Human Immunology
Volume:
63(7)
Page:
547-57
Original Article
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
Cancer Vaccines
2002
Authors:
Disis ML, Gooley TA, Rinn K, Davis D, Piepkorn M, Cheever MA, Knutson KL, Schiffman K
Journal:
Journal of Clinical Oncology
Volume:
20(11)
Page:
2624-32
Original Article
Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity
Cancer Vaccines
2002
Authors:
Knutson KL, Schiffman K, Cheever MA, Disis ML
Journal:
Clinical Cancer Research
Volume:
8(5)
Page:
1014-8